Fortrea Holdings (FTRE) EBT Margin (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly EBT Margin came in at 0.18% in Q2 2026, up 5201.0% on a YoY basis from 0.0% in Q2 2025, and up 90.84% quarter-over-quarter from 1.93% in Q1 2026.
Powered by 
Analysis
Fortrea Holdings (FTRE) EBT Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported EBT Margin for 5 consecutive years, with 0.18% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 5201.0% year-over-year to 0.18%; the trailing twelve-month figure through Jun 2026 stood at 2.91% (up 3475.0% YoY), and the FY2025 full-year result was 36.09%, down 2590.0% from the prior year.
- EBT Margin rose to 0.18% in Q2 2026 per FTRE's latest filing, from 1.93% in the prior quarter.
- Across five years, EBT Margin topped out at 10.54% in Q2 2022 and bottomed at 84.14% in Q1 2025.
- Historically, EBT Margin has averaged 10.27% across 5 years, with a median of 4.09% in 2025.
- The sharpest annual moves came in 2025 and 2026: EBT Margin tumbled 7271 bps in 2025, then soared 8221 bps in 2026.
- Over 5 years, EBT Margin stood at 1.65% in 2022, then tumbled by 367 bps to 7.71% in 2023, then slumped by 39 bps to 10.75% in 2024, then soared by 50 bps to 5.39% in 2025, then soared by 97 bps to 0.18% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 0.18%, 1.93%, and 5.39% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 6.89% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 21.44% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 5.30% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 4.47% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | -0.18% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -283.75% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | -3.58% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -105.20% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -15,194.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18% |
| Mar 31, 2026 | -1.93% |
| Dec 31, 2025 | -5.39% |
| Sep 30, 2025 | -4.09% |
| Jun 30, 2025 | -52.19% |
| Mar 31, 2025 | -84.14% |
| Dec 31, 2024 | -10.75% |
| Sep 30, 2024 | -5.30% |
| Jun 30, 2024 | -13.38% |
| Mar 31, 2024 | -11.43% |
| Dec 31, 2023 | -7.71% |
| Sep 30, 2023 | -3.07% |
| Jun 30, 2023 | 5.05% |
| Mar 31, 2023 | 1.37% |
| Dec 31, 2022 | -1.65% |
| Sep 30, 2022 | 9.73% |
| Jun 30, 2022 | 10.54% |